Paul Lévesque
Chief Executive Officer en THERATECHNOLOGIES INC. .
Fortuna: 120 848 $ al 31/03/2024
Perfil
Paul Lévesque is currently the President, Chief Executive Officer & Director at Theratechnologies, Inc. He previously worked as the Global President-Rare Disease at Pfizer Inc. from 2018 to 2020.
Prior to that, he held the position of Vice President-France & Canada Marketing at PF Consumer Healthcare Canada ULC.
Mr. Lévesque completed his undergraduate degree at McGill University and Université Laval.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
THERATECHNOLOGIES INC.
0.16% | 21/01/2024 | 72 800 ( 0.16% ) | 120 848 $ | 31/03/2024 |
Cargos activos de Paul Lévesque
| Empresas | Cargo | Inicio |
|---|---|---|
| THERATECHNOLOGIES INC. | Chief Executive Officer | 06/04/2020 |
Antiguos cargos conocidos de Paul Lévesque.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 06/04/2020 |
PF Consumer Healthcare Canada ULC
 PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Chief Tech/Sci/R&D Officer | - |
Formación de Paul Lévesque.
| Université Laval | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| THERATECHNOLOGIES INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
PF Consumer Healthcare Canada ULC
PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Paul Lévesque
